Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harter

Showing results (681-690 of 1,729) with videos related to

Pageof 173
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Phase I combined modality clinical trial of alpha-2-interferon and radiotherapyJ Torrisi, C Berg, K Harter, et al.
Biotechnology and Bioengineering|January 3, 2024
Identification of yttrium oxide-specific peptides for future recycling of rare earth elements from electronic scrapDanielle Maass, Peter Boelens, Christoph Bloss, et al.
Expert Review of Anticancer Therapy|July 22, 2010
Clinical management of borderline ovarian tumorsF Trillsch, S Mahner, Jd Ruetzel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 27, 2006
Sleep: a marker of physical and mental health in the elderlyKathryn J Reid, Zoran Martinovich, Sanford Finkel, et al.
Plant Signaling & Behavior|May 28, 2011
The activation of the Arabidopsis P-ATPase 1 by the brassinosteroid receptor BRI1 is independent of threonine 948 phosphorylationJanika Witthöft, Katharina Caesar, Kirstin Elgass, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2012
Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancerAndreas du Bois, Christian Marth, Jacobus Pfisterer, et al.
Protein Expression and Purification|June 1, 1992
Expression of the adenovirus E1B 175R protein and its association with membranes of Escherichia coliB Dalie, J L Ko, D M Wang, et al.
Oncology Letters|November 4, 2017
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumorsOliver Bähr, Stefanie Gross, Patrick N Harter, et al.
American Journal of Public Health|November 1, 1985
A three-state study of waterborne disease surveillance techniquesL Harter, F Frost, R Vogt, et al.
Journal of Food Protection|November 30, 2007
Prevalence and antimicrobial resistance of Salmonella recovered from processed poultrySalina Parveen, Maryam Taabodi, Jurgen G Schwarz, et al.
Pageof 173

Showing results (681-690 of 1,729) with videos related to

Sort By:
Pageof 173
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Phase I combined modality clinical trial of alpha-2-interferon and radiotherapyJ Torrisi, C Berg, K Harter, et al.
Biotechnology and Bioengineering|January 3, 2024
Identification of yttrium oxide-specific peptides for future recycling of rare earth elements from electronic scrapDanielle Maass, Peter Boelens, Christoph Bloss, et al.
Expert Review of Anticancer Therapy|July 22, 2010
Clinical management of borderline ovarian tumorsF Trillsch, S Mahner, Jd Ruetzel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 27, 2006
Sleep: a marker of physical and mental health in the elderlyKathryn J Reid, Zoran Martinovich, Sanford Finkel, et al.
Plant Signaling & Behavior|May 28, 2011
The activation of the Arabidopsis P-ATPase 1 by the brassinosteroid receptor BRI1 is independent of threonine 948 phosphorylationJanika Witthöft, Katharina Caesar, Kirstin Elgass, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2012
Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancerAndreas du Bois, Christian Marth, Jacobus Pfisterer, et al.
Protein Expression and Purification|June 1, 1992
Expression of the adenovirus E1B 175R protein and its association with membranes of Escherichia coliB Dalie, J L Ko, D M Wang, et al.
Oncology Letters|November 4, 2017
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumorsOliver Bähr, Stefanie Gross, Patrick N Harter, et al.
American Journal of Public Health|November 1, 1985
A three-state study of waterborne disease surveillance techniquesL Harter, F Frost, R Vogt, et al.
Journal of Food Protection|November 30, 2007
Prevalence and antimicrobial resistance of Salmonella recovered from processed poultrySalina Parveen, Maryam Taabodi, Jurgen G Schwarz, et al.
Pageof 173